United Kingdom: Healthcare

This report examines critical commercial, legal and regulatory challenges facing life sciences and healthcare companies globally, from shareholder activism and AI-powered drug...

The ASA and CAP's Annual Report 2025 reveals a fundamental transformation in UK advertising regulation, with AI-enabled monitoring now scanning nearly 60 million online ads and proactive enforcement overtaking reactive complaints work. From prescription weight-loss medicines to influencer disclosures and green claims, the report exposes critical compliance gaps across multiple sectors while signaling an era of unprecedented data-driven scrutiny.

In a recent LSIPR article published for World Health Day 2026, the spotlight is on the growing momentum in women’s health innovation, and the persistent gaps that still hamper progress.

WHOOP, the fitness wearable maker, have just announced the launch of a new blood test biomarker package designed to aid in the tracking of women's health, called the Women's Health Specialized Blood Biomarker Panel...

Parental Alcohol Misuse (PAM) remains a significant safeguarding concern across England. Tens of thousands of children live with a parent whose alcohol...

We spend a great deal of time advising private equity sponsors on European real estate transactions from our London office.

In this episode of Fear Less, Do More, host Gill Hunter speaks with Sarah Daniel, founder of MOTIONrehab, about pioneering neurological rehabilitation and how innovation is reshaping patient outcomes.

Therapeutic antibodies are at the heart of innovations in biotechnology and healthcare. With increasing regulatory requirements and quality expectations, critical quality attributes (CQAs)...

Compliance is never really optional, but this is especially true in healthcare; it's the backbone of patient trust, ethical operations and organizational success.